EDA Stock Overview
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
EDAP TMS S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.70 |
| 52 Week High | US$10.90 |
| 52 Week Low | US$3.06 |
| Beta | 0.64 |
| 1 Month Change | -5.63% |
| 3 Month Change | 10.74% |
| 1 Year Change | -36.79% |
| 3 Year Change | 25.23% |
| 5 Year Change | 78.19% |
| Change since IPO | 357.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| EDA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.7% | -1.9% | -0.5% |
| 1Y | -36.8% | -12.2% | 2.5% |
Return vs Industry: EDA underperformed the German Medical Equipment industry which returned -12.2% over the past year.
Return vs Market: EDA underperformed the German Market which returned 2.5% over the past year.
Price Volatility
| EDA volatility | |
|---|---|
| EDA Average Weekly Movement | 7.3% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: EDA has not had significant price volatility in the past 3 months.
Volatility Over Time: EDA's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 307 | Ryan Rhodes | www.edap-tms.com |
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications.
EDAP TMS S.A. Fundamentals Summary
| EDA fundamental statistics | |
|---|---|
| Market cap | €253.55m |
| Earnings (TTM) | -€21.18m |
| Revenue (TTM) | €60.42m |
4.2x
P/S Ratio-12.0x
P/E RatioIs EDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EDA income statement (TTM) | |
|---|---|
| Revenue | €60.42m |
| Cost of Revenue | €36.01m |
| Gross Profit | €24.41m |
| Other Expenses | €45.59m |
| Earnings | -€21.18m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 16, 2024
| Earnings per share (EPS) | -0.57 |
| Gross Margin | 40.40% |
| Net Profit Margin | -35.05% |
| Debt/Equity Ratio | 10.7% |
How did EDA perform over the long term?
See historical performance and comparison